Vaccine Rollout Hits First U.S. Snags With Delays, Allergic Case

Dec. 16, 2020, 9:05 PM

The first known allergic reaction to the Pfizer Inc. Covid-19 vaccine in the U.S. was reported in Alaska as some snarls began to emerge in the effort to send the shots across the country, highlighting the daunting challenges ahead for a historic immunization drive.

A health-care worker in Juneau, Alaska, with no history of allergies experienced flushing and shortness of breath 10 minutes after receiving a shot, the state health department said in a statement Wednesday.

The person was admitted to the emergency room and was given Pepcid, Benadryl and epinephrine through an intravenous drip. The patient stayed overnight and ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.